Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination

Vaccine

Volumn 25, Issue 52, 2007, Pages 8726-8731

  Salleras, L ^a   Dominguez A ^a,b   Bruguera, M ^c   Plans, P ^b   Costa, J ^c   Cardenosa N ^b   Batalla, J ^b   Plasencia A ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Directorate of Public Health   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

HBsAg and anti HBc; Hepatitis B; Prevalence

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BIRTHPLACE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; JUVENILE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SOCIAL ASPECT; SPAIN; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 36749019633     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.027     Document Type: Article

References (23)

1. Buti M., Esteban R., Jardí R., Sanz A., de Luis M., Roget M., et al. Epidemiology of acute hepatitis B. Gastroenterol Hepatol 11 (1988) 514-517
2. Vargas V., Pedreira J.D., Esteban R., Hernández J.M., Piqueras J., and Guardia J. Serologic markers for Hepatitis B virus in a group of healthy individuals. Med Clin (Barc) 78 (1982) 265-267
3. Bruguera M., and Sánchez Tapias J.M. The epidemiology of hepatitis B in Spain. Med Clin (Barc) 95 (1990) 470-475
4. Salleras L., Bruguera J.M., Vidal J., Taberner J.L., Plans P., Bayas J.M., et al. Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 8 (1992) 640-644
5. Salleras L., and Domínguez A. Vaccination against Hepatitis B. Vacunas 7. Suppl 1 (2006) 31-36
6. Salleras L. Hepatitis B vaccination. Gastroenterol Hepatol 29 (2006) 2-6
7. Salleras L., Bruguera M., Vidal J., Batalla J., Plans P., Navas E., et al. Hepatitis B vaccination stategies in Catalonia. Gastroenterol Hepatol 16 (1993) 140-146
8. Office of Population Census and Surveys. Classification of occupations. London: Office of Population Census; 1980.
9. Institut d'Estadística de Catalunya. Natural population movement in Catalonia 2002 and 2003. www.idescat.es.
10. Domínguez A., Bruguera M., Vidal J., Plans P., and Salleras L. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 18 (2000) 2345-2350
11. McQuillan G.M., Townsend T.R., Fields H.A., Carroll M., Leahy M., and Polk B.F. Seroepidemiology of hepatitis B virus infection in the United States 1976-1980. Am J Med 87 3A (1989) 5S-10S
12. Kane M.A., Alter M.J., Hadler S.C., and Margolis H.S. Hepatitis B infection in the United States. Recent trends and future strategies for control. Am J Med 87 3A (1989) 11S-13S
13. Harpaz R., McMahon B.J., Margolis H.S., Shapiro C.N., Havron D., Carpenter G., et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis 181 (2000) 413-418
14. Furusyo N., Hayashi J., Sawayama Y., Kawakami Y., Kishihara Y., and Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period. Am J Trop Med Hyg 59 (1998) 693-698
15. Gay N.J., Hesketh L.M., Osborne K.P., Farrington C.P., Morgan-Capner P., and Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect 122 (1999) 33-38
16. Lindh M., Norkrans G., Stenqvist K., Eriksson K., and Taranger J. Hepatitis B carriers in Sweden-effects of immigration. Scand J Infect Dis 25 (1993) 411-416
17. Baldo V., Floreani A., Menegon T., Grella P., Paternoster D.M., and Trivello R. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: a seroepidemiological study. Eur J Epidemiol 16 (2000) 87-91
18. Bonura F., Sorgi M., Perna A.M., Puccio G., Tramuto F., Cajozzo C., et al. Pregnant women as a sentinel population to target and implement hepatitis B virus (HBV) vaccine coverage: a three-year survey in Palermo, Sicily. Vaccine 23 (2005) 3243-3246
19. Department of Health. Generalitat of Catalonia. Summary of notifiable diseases during the years 1990 and 1991. Butlletí Epidemiol Catalunya 1992;XIII:55-6.
20. Department of Health. Generalitat of Catalonia. Summary of notifiable diseases during 2005. Butlletí Epidemiol Catalunya 2007;XXVIII:13-21.
21. Salleras L., Bruguera M., Taberner J.L., Domínguez A., Batalla J., and Buti M. Effectiveness of the mass antihepatitis B vaccination program in preadolescents in Catalonia. Med Clin (Barc) 121 Suppl 1 (2003) 79-82
22. Salleras L., Dominguez A., Bruguera M., Cardenosa N., Batalla J., Carmona G., et al. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 23 (2005) 2181-2184
23. Giacchino R., Zancan L., Vajro P., Verucchi G., Resti M., Barbera C., et al. Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination. Infection 29 (2001) 188-191